Mikel Urretavizcaya

Papers

Total Citations

H-Index

About

Mikel Urretavizcaya is a leading researcher in occupational exposure assessment and pharmaceutical safety, with a focus on the handling of hazardous medicinal products (HMPs). His work is pivotal in evaluating the risks associated with antineoplastic drug preparation, particularly in the context of emerging robotic compounding technologies. Urretavizcaya’s major contribution lies in demonstrating that robotic systems can significantly reduce surface contamination from hazardous drugs, thereby enhancing worker safety in healthcare settings. His most-cited study, "Monitoring of occupational exposure to hazardous medicinal products in robotic compounding," has garnered 2 citations since 2025, reflecting its timely relevance as hospitals adopt automation to mitigate exposure risks. This research provides critical data for developing safer compounding protocols and informs regulatory standards for occupational hygiene. Urretavizcaya’s work bridges engineering, pharmacy, and public health, offering practical solutions for protecting healthcare personnel. His findings are essential for students and researchers interested in exposure science, pharmaceutical safety, and the integration of robotics in healthcare environments.